Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Personalized Diabetes Medicine Program, |
RCV000445502 | SCV000537078 | uncertain significance | Monogenic diabetes | 2016-08-16 | criteria provided, single submitter | research | ACMG Criteria: PP3, BP4 |
Clinical Genomics, |
RCV002246123 | SCV002513530 | uncertain significance | Transitory neonatal diabetes mellitus | criteria provided, single submitter | research | Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant (rs763104338) in neonatal diabetes yet. | |
Clinical Genomics, |
RCV002246122 | SCV002513531 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant (rs763104338) in MODY yet. | |
Fulgent Genetics, |
RCV002481354 | SCV002789402 | uncertain significance | Diabetes mellitus, transient neonatal, 2; Hyperinsulinemic hypoglycemia, familial, 1; Leucine-induced hypoglycemia; Type 2 diabetes mellitus; Diabetes mellitus, permanent neonatal 3 | 2021-12-21 | criteria provided, single submitter | clinical testing |